Amsterdam, The Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as healthcare leaders navigate a changed world'. Now in its seventh year, the Future Health Index 2022 report, based on proprietary research from almost 3,000 respondents conducted across 15 countries, explores how healthcare leaders are harnessing the power of data and digital technology as they look to address their key challenges coming out of the pandemic.

The 2022 report paints a picture of a sector that is radically re-evaluating priorities as it strives to deliver improved patient care. 'As we emerge from the pandemic, healthcare leaders worldwide are embarking on a reboot,' said Jan Kimpen, Chief Medical Officer, Philips. 'Many are refocusing on both new and existing priorities, from addressing staff shortages and extending care delivery, to leveraging big data and predictive analytics.'

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries.

Contact:

Kathy O'Reilly

Philips Global Press Office

Tel: +1 978-221-8919

(C) 2022 Electronic News Publishing, source ENP Newswire